Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

This study has been completed.
Sponsor:
Collaborator:
British Medical Research Council
Information provided by:
Sarepta Therapeutics
ClinicalTrials.gov Identifier:
NCT00844597
First received: December 24, 2008
Last updated: April 22, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
No publications provided by Sarepta Therapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):